SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MikeM54321 who wrote (190)4/22/1998 12:37:00 AM
From: Pseudo Biologist  Read Replies (1) of 3044
 
Mike, the "particular fellow" is indeed Lander, and the paragraph you cite is consistent with what the company has said in the past. Namely, Lander cannot, according to MIT/Whitehead rules, hold stock in, and receive funding from, the same company. In last year's proxy Lander was listed as holding about 700,000 shares of MLNM; in this year's his holdings are down to 20-30K.

Here is the release announcing the establishment of the genomics center with Lander as head:

mlnm.com

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News